COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 1 for:    NCT03340883
Previous Study | Return to List | Next Study

Safety and Tolerability of BION-1301 in Adults With Relapsed or Refractory Multiple Myeloma (MM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03340883
Recruitment Status : Terminated (No objective responses observed following completion of Phase 1 dose-escalation)
First Posted : November 14, 2017
Last Update Posted : August 5, 2019
Information provided by (Responsible Party):
Aduro Biotech, Inc.